Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: maternal and prenatal evaluations.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Toxicological Sciences

• Publication date

  2003-08-01

• Fields of study

  Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1093/TOXSCI/KFG121PMID 12773773
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sub-chronic dietary toxicity of potassium perfluorooctanesulfonate in rats.

  2003influential reference
• Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation.

  2003cited by this paper
• Structural determinants of fluorochemical-induced mitochondrial dysfunction.

  2002cited by this paper
• Inhibition of gap junctional intercellular communication by perfluorinated compounds in rat liver and dolphin kidney epithelial cell lines in vitro and Sprague-Dawley rats in vivo.

  2002cited by this paper
• Perfluorooctane Sulfonate in Oysters, Crassostrea virginica, from the Gulf of Mexico and the Chesapeake Bay, USA

  2002cited by this paper
• Concentrations of perfluorinated acids in livers of birds from Japan and Korea.

  2002cited by this paper
• Interactions of flurochemicals with rat liver fatty acid-binding protein

  2002cited by this paper
• Subchronic toxicity studies on perfluorooctanesulfonate potassium salt in cynomolgus monkeys.

  2002cited by this paper
• Perfluorooctanoate, perflourooctanesulfonate, and N-ethyl perfluorooctanesulfonamido ethanol; peroxisome proliferation and mitochondrial biogenesis.

  2002cited by this paper
• Developmental exposure to brominated diphenyl ethers results in thyroid hormone disruption.

  2002cited by this paper
• Perfluorooctanesulfonate and related fluorinated hydrocarbons in marine mammals, fishes, and birds from coasts of the Baltic and the Mediterranean Seas.

  2002cited by this paper
• Interactions of fluorochemicals with rat liver fatty acid-binding protein.

  2002cited by this paper
• Potential Consequences of Maternal Hypothyroidism on the Offspring: Evidence and Implications

  2001cited by this paper
• Growing concern over perfluorinated chemicals.

  2001cited by this paper
• Rat and rabbit oral developmental toxicology studies with two perfluorinated compounds.

  2001cited by this paper
• Global distribution of perfluorooctane sulfonate in wildlife.

  2001cited by this paper
• 7-Dehydrocholesterol-dependent proteolysis of HMG-CoA reductase suppresses sterol biosynthesis in a mouse model of Smith-Lemli-Opitz/RSH syndrome.

  2001cited by this paper
• Accumulation of perfluorooctane sulfonate in marine mammals.

  2001cited by this paper
• Perfluorooctane sulfonate in fish-eating water birds including bald eagles and albatrosses.

  2001cited by this paper
• Compound-specific, quantitative characterization of organic fluorochemicals in biological matrices.

  2001cited by this paper
• Examination of the axial skeleton of fetal rodents.

  2000cited by this paper
• Is neuropsychological development related to maternal hypothyroidism or to maternal hypothyroxinemia?

  2000cited by this paper
• Serum perfluorooctane sulfonate and hepatic and lipid clinical chemistry tests in fluorochemical production employees.

  1999cited by this paper
• Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child.

  1999cited by this paper
• Subchronic Toxicity Study in Rats with 1-Methyl-3-propylimidazole-2-thione (PTI): Effects on the Thyroid

  1995cited by this paper
• Benchmark Dose Workshop: criteria for use of a benchmark dose to estimate a reference dose.

  1995cited by this paper
• Subchronic toxicity study in rats with 1-methyl-3-propylimidazole-2-thione (PTI): effects on the thyroid.

  1995cited by this paper
• Alteration of thyroid homeostasis by UDP-glucuronosyltransferase inducers in rats: a dose-response study.

  1995cited by this paper
• Developmental exposure to polychlorinated biphenyls (Aroclor 1254) reduces circulating thyroid hormone concentrations and causes hearing deficits in rats.

  1995cited by this paper
• Dose-response assessment for developmental toxicity. II. Comparison of generic benchmark dose estimates with no observed adverse effect levels.

  1994cited by this paper
• Dose-response assessment for developmental toxicity

  1994cited by this paper
• Thyroxine and 3,5,3'-triiodothyronine production, metabolism, and distribution in pregnant rat near term.

  1994cited by this paper
• HMG-CoA reductase mRNA in the post-implantation rat embryo studied by in situ hybridization.

  1993cited by this paper
• The role of thyroid hormones in prenatal and neonatal neurological development--current perspectives.

  1993cited by this paper
• Perfluorooctane sulfonic acid is a potent inducer of peroxisomal fatty acid beta-oxidation and other activities known to be affected by peroxisome proliferators in mouse liver.

  1993cited by this paper
• The mechanism underlying the hypolipemic effect of perfluorooctanoic acid (PFOA), perfluorooctane sulphonic acid (PFOSA) and clofibric acid.

  1992cited by this paper
• Low plasma triiodothyronine concentrations and outcome in preterm infants.

  1988cited by this paper
• Volume homeostasis during pregnancy in the rat.

  1987cited by this paper
• Hypothyroidism and abnormalities in the kinetics of thyroid hormone metabolism in rats treated chronically with polychlorinated biphenyl and polybrominated biphenyl.

  1987cited by this paper
• A new method for determining allowable daily intakes.

  1986cited by this paper
• Effects of low subchronic doses of methoxychlor on the rat hypothalamic-pituitary reproductive axis.

  1986cited by this paper
• A new method for determining allowable daily intakes.

  1984cited by this paper
• Cholestyramine-enhanced fecal elimination of carbon-14 in rats after administration of ammonium [14C]perfluorooctanoate or potassium [14C]perfluorooctanesulfonate.

  1984cited by this paper
• Propylthiouracil (PTU) pharmacology in the rat. II. Effects of PTU on thyroid function.

  1983cited by this paper
• Blood flow during pregnancy in the rat: I. Flow patterns to maternal organs.

  1982cited by this paper
• Changes in the composition of maternal plasma, fetal plasma and fetal extraembryonic fluid during gestation in the rat.

  1977cited by this paper
• THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.

  1963cited by this paper

• Effects of Perfluorooctane sulfonate (PFOS) and Tetrabromobisphenol A (TBBPA) on Reproductive Development in Rats.

  2026cites this paper
• From association to mechanism: Prenatal PFAS Co-exposures induces fetal neural tube defects via autophagy-mediated ferroptosis.

  2026cites this paper
• In vitro and in vivo thyroid hormone system disruption by perfluorooctane sulfonate (PFOS) and tetrabromobisphenol A (TBBPA).

  2025cites this paper
• Range of the perfluorooctanoate (PFOA) safe dose for human health: an international collaboration

  2025cites this paper
• Fetal exposure to perfluoroalkyl substances (PFAS) in drinking water and congenital malformations: A nation-wide register-based study on PFAS in drinking water.

  2025cites this paper
• Effects of Perfluorobutane Sulfonate (PFBS) on Female Reproduction, Pregnancy, and Birth Outcomes.

  2025cites this paper
• A comparative toxicological and epidemiological evaluation of dioxins and PFAS chemicals

  2025cites this paper
• Adolescent Bone Health Under Threat: PFAS Mixtures as Drivers of Skeletal Fragility

  2025cites this paper
• Estimating safe doses of perfluorooctane sulfonate (PFOS): an international collaboration

  2025cites this paper
• Designing Ultraporous Mesostructured Silica Nanoparticles for the Remediation of Per- and Polyfluoroalkyl Substances.

  2025cites this paper
• Endocrine-disrupting chemicals in metabolic bone diseases, including osteoporosis

  2025cites this paper
• Can four decades of experience with dioxins inform scientists and regulatory agencies about how to regulate PFAS chemicals?

  2025cites this paper
• Effects of perfluorooctane sulfonate (PFOS) on a novel reptilian toxicity test species, the brown anole (anolis sagrei).

  2025cites this paper
• The association between maternal perfluoroalkylated substances exposure and neonatal birth weight: a system review and meta-analysis

  2025cites this paper
• Potential human health effects of per- and polyfluoroalkyl substances (PFAS) prevalent in aquatic environment: a review

  2025cites this paper
• PFOS caused fertility defects and disrupted spermatogenic gene networks in the male medaka with a transgenerational history of ancestral BPA exposure.

  2025cites this paper
• Fluorotelomer ethoxylates cause developmental toxicity in mice

  2024cites this paper
• A second hit by PFOS exposure exacerbated developmental defects in medaka embryos with a history of ancestral BPA exposure.

  2024cites this paper
• PFOS impairs cardiac function and energy metabolism under high-fat diet: Insights into role of circulating macrophage emphasized by exposure distribution.

  2024cites this paper
• Mode of Action Criteria for Selection of the Critical Effect and Safe Dose Range for PFOA by the Alliance for Risk Assessment.

  2024cites this paper
• Maternal PFOS exposure affects offspring development in Nrf2-dependent and independent ways in zebrafish (Danio rerio).

  2024cites this paper
• Perfluorooctane sulfonate (PFOS) induced bone loss by inhibiting FoxO1-mediated defense against oxidative stress in osteoblast.

  2024cites this paper
• Dose-Dependent Effects of PFOS on Thyroid Hormone-Driven Neurodevelopment and Metamorphic-like change in Xenopus laevis larvae

  2024cites this paper
• Prenatal Perfluoroalkyl Substance Exposure in Association with Global Histone Post-Translational Methylation in 2-Year-Old Children

  2024cites this paper
• Association between prenatal perfluorinated compounds exposure and risk of pregnancy complications: A meta-analysis.

  2024cites this paper
• Perfluorooctanesulfonic acid (PFOS) disrupts cadherin-16 in the developing rat thyroid gland

  2024cites this paper
• Exploring the sources, occurrence, transformation, toxicity, monitoring, and remediation strategies of per- and polyfluoroalkyl substances: a review

  2024cites this paper
• High-Throughput Screening of ToxCast PFAS Chemical Library for Potential Inhibitors of the Human Sodium Iodide Symporter.

  2023cites this paper
• Metabolic perturbations in pregnant rats exposed to low-dose perfluorooctanesulfonic acid: An integrated multi-omics analysis.

  2023cites this paper
• Health Risk Exposure Assessment of Migration of Perfluorooctane Sulfonate and Perfluorooctanoic Acid from Paper and Cardboard in Contact with Food under Temperature Variations

  2023cites this paper
• Endocrine-disrupting chemicals and autoimmune diseases.

  2023cites this paper
• Toxicological Mechanisms of Emerging Per-/poly-fluoroalkyl Substances: Focusing on Transcriptional Activity and Gene Expression Disruption.

  2023cites this paper
• Perfluorooctane sulfonic acid modulates expression of placental steroidogenesis-associated genes and hormone levels in pregnant rats.

  2023cites this paper
• Restoring Angiotensin Type 2 Receptor Function Reverses PFOS-Induced Vascular Hyper-Reactivity and Hypertension in Pregnancy

  2023cites this paper
• Dose additive maternal and offspring effects of oral maternal exposure to a mixture of three PFAS (HFPO-DA, NBP2, PFOS) during pregnancy in the Sprague-Dawley rat.

  2023cites this paper
• In vitro screening of per- and polyfluorinated substances (PFAS) for interference with seven thyroid hormone system targets across nine assays.

  2023cites this paper
• Ammonium Perchlorate: Serum Dosimetry, Neurotoxicity and Resilience of the Neonatal Rat Thyroid System.

  2023cites this paper
• Deleterious functional consequences of perfluoroalkyl substances accumulation into the myelin sheath

  2023cites this paper
• Antibiotic induced restructuring of the gut microbiota does not affect oral uptake and accumulation of perfluorooctane sulfonic acid (PFOS) in rats.

  2023cites this paper
• The Devil they Knew: Chemical Documents Analysis of Industry Influence on PFAS Science

  2022cites this paper
• Environmental fate and transportation of perfluorinated compounds

  2022cites this paper
• In silico analysis decodes transthyretin (TTR) binding and thyroid disrupting effects of per- and polyfluoroalkyl substances (PFAS)

  2022cites this paper
• Evaluating maternal exposure to an environmental per and polyfluoroalkyl substances (PFAS) mixture during pregnancy: Adverse maternal and fetoplacental effects in a New Zealand White (NZW) rabbit model.

  2022cites this paper
• Association between perfluoroalkyl substances concentration and bone mineral density in the US adolescents aged 12-19 years in NHANES 2005-2010

  2022cites this paper
• Perfluorooctane sulfonate exposure induces preeclampsia-like syndromes by damaging trophoblast mitochondria in pregnant mice.

  2022cites this paper
• Cumulative maternal and neonatal effects of combined exposure to a mixture of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS) during pregnancy in the Sprague-Dawley rat

  2022cites this paper
• Persistent impairment of gonadal development in rare minnow (Gobiocypris rarus) after chronic exposure to chlorinated polyfluorinated ether sulfonate.

  2022cites this paper
• Perfluorooctane sulfonate and perfluorooctanoic acid

  2022cites this paper
• Reproductive and developmental toxicity of perfluorooctane sulfonate (PFOS) in the white-footed mouse (Peromyscus leucopus).

  2022cites this paper
• The Role of Fecal Microbiota in Liver Toxicity Induced by Perfluorooctane Sulfonate in Male and Female Mice

  2022cites this paper
• Maternal perfluorooctane sulfonic acid exposure during rat pregnancy causes hypersensitivity to angiotensin II and attenuation of endothelium-dependent vasodilation in the uterine arteries

  2022cites this paper
• Internal Relative Potency Factors for the Risk Assessment of Mixtures of Per- and Polyfluoroalkyl Substances (PFAS) in Human Biomonitoring

  2022cites this paper
• PFOS disrupts key developmental pathways during hiPSC-derived cardiomyocyte differentiation in vitro.

  2022cites this paper
• Cerebral concentration and toxicity of endocrine disrupting chemicals: The implication of blood-brain interfaces.

  2022cites this paper
• PFOS-induced thyroid hormone system disrupted rats display organ-specific changes in their transcriptomes.

  2022cites this paper
• Sexually Dimorphic Accumulation of Persistent Organic Pollutants in Fetuses

  2022cites this paper
• A nationwide study of maternal exposure to ambient ozone and term birth weight in the United States.

  2022cites this paper
• Integration of Toxicogenomics and Physiologically Based Pharmacokinetic Modeling in Human Health Risk Assessment of Perfluorooctane Sulfonate.

  2022cites this paper
• Perfluoroalkyl Substances and Incident Natural Menopause in Midlife Women: The Mediating Role of Sex Hormones.

  2022cites this paper
• A Critical Review and Meta-Analysis of Impacts of Per- and Polyfluorinated Substances on the Brain and Behavior

  2022cites this paper
• Developmental toxicity of Nafion byproduct 2 (NBP2) in the Sprague-Dawley rat with comparisons to hexafluoropropylene oxide-dimer acid (HFPO-DA or GenX) and perfluorooctane sulfonate (PFOS).

  2021cites this paper
• Abstract. Perfluorooctane sulfonate (PFOS) is a persistent pollutant that exerts toxicity and induces cardiogenesis in humans and animals. Yet, the effect of PFOS exposure on cardiac toxicity in adult rats

  2021cites this paper
• Per- and Poly-fluoroalkyl Substances (PFAS) and Female Reproductive Outcomes: PFAS Elimination, Endocrine-Mediated Effects, and Disease.

  2021cites this paper
• The impact of perfluoroalkyl substances on pregnancy, birth outcomes, and offspring development: a review of data from mouse models

  2021influential citation
• Accumulation of PFAS by livestock – determination of transfer factors from water to serum for cattle and sheep in Australia

  2021cites this paper
• Environmental exposures, fetal testis development and function: phthalates and beyond.

  2021cites this paper
• Perfluoroalkyl substances and thyroid stimulating hormone levels in a highly exposed population in the Veneto Region.

  2021cites this paper
• Risk Assessment of Perfluorooctane Sulfonate (PFOS) using Dynamic Age Dependent Physiologically based Pharmacokinetic Model (PBPK) across human lifetime.

  2021cites this paper
• Thyroid Disruptors: Extrathyroidal Sites of Chemical Action and Neurodevelopmental Outcome-an Examination Using Triclosan and Perfluorohexane Sulfonate (PFHxS).

  2021cites this paper
• The role of maternal high fat diet on mouse pup metabolic endpoints following perinatal PFAS and PFAS mixture exposure.

  2021cites this paper
• Per- and polyfluoroalkyl substances (PFAS) in livestock and game species: A review.

  2021cites this paper
• Perfluorooctane sulfonate exerts inflammatory bowel disease-like intestinal injury in rats

  2021cites this paper
• Development of a Gestational and Lactational Physiologically Based Pharmacokinetic (PBPK) Model for Perfluorooctane Sulfonate (PFOS) in Rats and Humans and Its Implications in the Derivation of Health-Based Toxicity Values

  2021cites this paper
• Umbilical cord serum perfluoroalkyl substance mixtures in relation to thyroid function of newborns: Findings from Sheyang Mini Birth Cohort Study.

  2021cites this paper
• Perfluorooctane sulfonate induces heart toxicity involving cardiac apoptosis and inflammation in rats

  2021cites this paper
• Perfluoroalkyl substances in drinking water sources along the Yangtze River in Jiangsu Province, China: Human health and ecological risk assessment.

  2021cites this paper
• Perfluorooctane sulfonate induces autophagy-associated apoptosis through oxidative stress and the activation of extracellular signal–regulated kinases in renal tubular cells

  2021cites this paper
• Influence of perfluoroalkyl acids and other parameters on circulating thyroid hormones and immune-related microRNA expression in free-ranging nestling peregrine falcons.

  2021cites this paper
• Prenatal exposure to perfluoroalkyl substances and thyroid hormone concentrations in cord plasma in a Chinese birth cohort

  2020cites this paper
• Hexafluoropropylene oxide-dimer acid (HFPO-DA or GenX) alters maternal and fetal glucose and lipid metabolism and produces neonatal mortality, low birthweight, and hepatomegaly in the Sprague-Dawley rat.

  2020cites this paper
• Early-Life Environmental Toxic Influences on Neural Development

  2020cites this paper
• Temporal trends and determinants of serum concentrations of per- and polyfluoroalkyl substances among Northern California mothers with a young child, 2009-2016.

  2020cites this paper
• Nexus between perfluoroalkyl compounds (PFCs) and human thyroid dysfunction: A systematic review evidenced from laboratory investigations and epidemiological studies

  2020cites this paper
• Developmental Origins of Metabolic Disease.

  2020cites this paper
• Exposure to Perflouroalkyl acids and foetal and maternal thyroid status: a review

  2020cites this paper
• Probabilistic human health risk assessment of perfluorooctane sulfonate (PFOS) by integrating in vitro, in vivo toxicity, and human epidemiological studies using a Bayesian-based dose-response assessment coupled with physiologically based pharmacokinetic (PBPK) modeling approach.

  2020cites this paper
• Application of the Key Characteristics of Carcinogens to Per and Polyfluoroalkyl Substances

  2020cites this paper
• Producing Ignorance Through Regulatory Structure: The Case of Per- and Polyfluoroalkyl Substances (PFAS)

  2020cites this paper
• Outcome of a public consultation on the draft risk assessment of perfluoroalkyl substances in food

  2020cites this paper
• Typical organic pollutant-protein interactions studies through spectroscopy, molecular docking and crystallography: A review.

  2020cites this paper
• Intestinal environmental disorders associate with the tissue damages induced by perfluorooctane sulfonate exposure.

  2020cites this paper
• Environmental neurotoxic pollutants: review

  2020cites this paper
• Toxicity of Balb-C Mice Exposed to Recently Identified 1,1,2,2-Tetrafluoro-2-[1,1,1,2,3,3-hexafluoro-3-(1,1,2,2-tetrafluoroethoxy)propan-2-yl]oxyethane-1-sulfonic acid (PFESA-BP2).

  2020cites this paper
• A Probabilistic Approach to Evaluate the Risk of Decreased Total Triiodothyronine Hormone Levels following Chronic Exposure to PFOS and PFHxS via Contaminated Drinking Water

  2020cites this paper
• Early-life Environmental Exposure and Disease: Facts and Perspectives

  2020cites this paper
• Neurotoxic Effects of Lactational Exposure to Perfluorooctane Sulfonate on Learning and Memory in Adult Male Mouse.

  2020cites this paper
• The 3M Company (3M) appreciates the opportunity to review and comment on the EFSA’s draft scientific opinion on the “Risk to human health related to the presence of perfluoroalkyl

  2020cites this paper
• Perfluoroalkyl chemicals in neurological health and disease: Human concerns and animal models.

  2020cites this paper
• What are the effects of PFAS exposure at environmentally relevant concentrations?

  2020cites this paper
• Per‐ and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research

  2020cites this paper